A Path To Novel Mental Health Therapies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scientific Journal Article follows notable IP updates, including publication of key PCT Patent Application, presentation at International Society for Research into Psychedelics ConferenceVANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased that ....

United States , New Orleans , British Columbia , United Kingdom , Harpreet Kaur , Nick Kadysh , Nicholas Kadysh , William Fantegrossi , James Gauld , A Path To Novel Mental Health Therapies , Neither The Canadian Securities Exchange , University Of Waterloo , Pharmala Biotech Holdings Inc , International Society For Research , University Of Arkansas , Regulation Services Provider , Research At Pharmala Biotech , Scientific Journal Article , International Society , Ala Biotech Holdings , Drug Discovery , Structure Activity Relationships , Novel Mental Health , Patent Prosecution Highway , Medical Sciences , Pharmala Biotech ,